ERBB2 and cancer: Allowing detection limits as low as 20 aM for miRNA and 0.6 fM for HER2 proteins, which offer diagnostics faster and more precisely than previous methods, this study depicts the potential of FET biosensors in revolutionizing diagnostics for cancer.98